Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine diseases affecting women of reproductive age. The pathogeny of PCOS is still not completely understood, but one contributing factor that has been proposed is anti-Müllerian hormone (AMH). There is currently no clear cor...
Main Authors: | Nada Ahmed, Asma A. Batarfi, Osama S. Bajouh, Sherin Bakhashab |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/9/4/136 |
Similar Items
-
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01) -
Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: Correlation with clinical, hormonal and ultrasonographic parameters
by: Adel F. Begawy, et al.
Published: (2010-10-01) -
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
by: Mala S. Sivanandy, et al.
Published: (2023-02-01) -
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress
by: Awadhesh Kumar Singh, et al.
Published: (2015-01-01) -
Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
by: Nathalie di Clemente, et al.
Published: (2022-10-01)